Placebo (NNC0480-0389)

DRUG2 trials

Sponsors

Novo Nordisk A/S

Conditions

Diabetes Mellitus, Type 2Healthy VolunteersHealthy Volunteers Type 2 DiabetesObesityOverweight

Phase 1

First Research Study to Look at How Two Medicines, NNC0480-0389 and Semaglutide, Work Together in Healthy People, in People With High Body Weight and in People With Diabetes

CompletedNCT04259801

Novo Nordisk A/SDiabetes Mellitus, Type 2, Healthy Volunteers, Obesity +1

Start: 2020-02-17End: 2022-03-16Updated: 2023-11-13

A Research Study of How the Medicine NNC0480-0389 Taken With Semaglutide Works in the Body of Healthy Japanese Men

CompletedNCT04878406

Novo Nordisk A/SHealthy Volunteers Type 2 Diabetes

Start: 2021-05-18End: 2021-07-20Updated: 2023-05-17